Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | TP53 | P04637 | 1/20 | 0.61 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA1 | P00915 | 1/20 | 0.58 |
| ▸ | CA2 | P00918 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
| ▸ | XDH | P47989 | 1/20 | 0.53 |
| ▸ | NPC1 | O15118 | 5/20 | 0.53 |
| ▸ | RAB9A | P51151 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.53 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.53 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15896952 | 0.97 | CLK4 (0.61) | CLK4MAPTKDM4ETP53CA12 | |
| SCHEMBL2876553 | 0.97 | CLK4 (0.61) | CLK4MAPTKDM4ETP53CA12 | |
| SCHEMBL7646098 | 0.91 | S1PR1 (0.66) | CLK4MAPTKDM4ENPC1RAB9A | |
| SCHEMBL14264452 | 0.91 | MAPT (0.66) | CLK4MAPTKDM4ETP53CA12 | |
| SCHEMBL19175445 | 0.91 | MAPT (0.66) | CLK4MAPTKDM4ETP53CA12 | |
| SCHEMBL19175444 | 0.89 | CLK4 (0.53) | CLK4MAPTKDM4ETP53CA12 | |
| SCHEMBL15805573 | 0.89 | ESR2 (0.72) | CLK4MAPTKDM4ETP53NPC1 | |
| SCHEMBL3418789 | 0.89 | DYRK1A (0.58) | CLK4MAPTKDM4ETP53NPC1 | |
| SCHEMBL7801135 | 0.89 | CHRNA7 (0.55) | CLK4MAPTKDM4ETP53CA12 | |
| SCHEMBL19275034 | 0.87 | CLK4 (0.52) | CLK4MAPTKDM4ETP53CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102448429-B | Benzylidene malonates | 巴斯夫欧洲公司 | 2018-03-06 | — | — | CN | claimed |
| EP-1768644-B1 | LIGHT PROTECTING-EFFECTIVE COSMETIC OR DERMATOLOGICAL PREPARATIONS | CIBA HOLDING INC (CH) | 2009-02-18 | — | — | EP | claimed |
| EP-3769624-B1 | ENHANCING THE ANTIMICROBIAL ACTIVITY OF BIOCIDES WITH POLYMERS | BASF SE (DE) | 2024-10-30 | — | — | EP | disclosed |
| CN-112074736-B | UV filter composition, method for the production thereof and use thereof | 巴斯夫欧洲公司 | 2024-10-01 | — | — | CN | disclosed |
| US-20240108556-A1 | SCAR TREATMENT COMPOSITION | TOPIX PHARMACEUTICALS, INC. | 2024-04-04 | — | — | US | disclosed |
| US-20240075112-A1 | SCAR TREATMENT COMPOSITION | TOPIX PHARMACEUTICALS, INC. | 2024-03-07 | — | — | US | disclosed |
| US-11793742-B2 | Mixtures of cosmetic UV absorbers | BASF SE (DE) | 2023-10-24 | — | — | US | disclosed |
| CN-116782923-A | Scar treatment composition | 塔普克斯制药公司 | 2023-09-19 | — | — | CN | disclosed |
| CN-116710081-A | Scar treatment composition | 塔普克斯制药公司 | 2023-09-05 | — | — | CN | disclosed |
| US-11666050-B2 | Enhancing the antimicrobial activity of biocides with polymers | BASF SE (DE) | 2023-06-06 | — | — | US | disclosed |
| US-11647746-B2 | Enhancing the antimicrobial activity of biocides with polymers | BASF SE (DE) | 2023-05-16 | — | — | US | disclosed |
| US-20070104662-A1 | Ultraviolet ray absorbing composite powder | IWASE COSFA CO., LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-7192453-B2 | Method of coloring keratin-containing fibres using diazonium salts | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2007-03-20 | — | — | US | disclosed |
| US-20060162095-A1 | Method of colouring porous material | CIBA SPECIALTY CHEMICALS CORP. | 2006-07-27 | — | — | US | disclosed |
| US-20050251932-A1 | Method of colouring porous material | CIBA SPECIALTY CHEMICALS CORP. | 2005-11-17 | — | — | US | disclosed |
| CN-1678285-A | Dyeing method for porous material | CIBA SC HOLDING AG (CH) | 2005-10-05 | — | — | CN | disclosed |
| CN-1678284-A | Dyeing method for porous material | CIBA SC HOLDING AG (CH) | 2005-10-05 | — | — | CN | disclosed |
| US-20050129632-A1 | Uv absorber compositions comprising a hydroxyphenyltriazine compound | CIBA SPECIALTY CHEMICALS CORP. | 2005-06-16 | — | — | US | disclosed |
| US-20050000034-A1 | Yellow cationic dyes for dyeing of organic material | CIBA SPECIALTY CHEMICALS CORPORATION | 2005-01-06 | — | — | US | disclosed |
| US-3932402-A | Preparation of sym-triazines by trimerization of nitriles in trifluoromethanesulfonic acid | PHILLIPS PETROLEUM COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060162095-A1 | Method of colouring porous material | ACR, HLA-C, TYR | CLK4 2482/4885MAPT 2284/4885KDM4E 2481/4885 |
| US-20050000034-A1 | Yellow cationic dyes for dyeing of organic material | KRT18, PYCR1, CYC1 | CLK4 2103/4885MAPT 955/4885KDM4E 1285/4885 |
| US-20240108556-A1 | SCAR TREATMENT COMPOSITION | MMP1, MMP8, PLAT | CLK4 4661/4885MAPT 2871/4885KDM4E 2616/4885 |
| US-20050129632-A1 | Uv absorber compositions comprising a hydroxyphenyltriazine compound | C1R, C5, C3AR1 | CLK4 1948/4885MAPT 3054/4885KDM4E 2003/4885 |
| US-20050251932-A1 | Method of colouring porous material | TYR, SDHB, CYCS | CLK4 3879/4885MAPT 2909/4885KDM4E 1861/4885 |
| US-11647746-B2 | Enhancing the antimicrobial activity of biocides with polymers | CAT, AOC1, DDT | CLK4 2110/4885MAPT 4500/4885KDM4E 2071/4885 |
| US-20070104662-A1 | Ultraviolet ray absorbing composite powder | XRCC5, XRCC6, ERCC1 | CLK4 3826/4885MAPT 485/4885KDM4E 2674/4885 |
| US-20240075112-A1 | SCAR TREATMENT COMPOSITION | MMP1, MMP8, MMP2 | CLK4 4675/4885MAPT 2448/4885KDM4E 1907/4885 |
| US-11666050-B2 | Enhancing the antimicrobial activity of biocides with polymers | CAT, AOC1, DDT | CLK4 2110/4885MAPT 4500/4885KDM4E 2071/4885 |
| US-11793742-B2 | Mixtures of cosmetic UV absorbers | BTD, TMSB10, TH | CLK4 2932/4885MAPT 2781/4885KDM4E 1877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.